This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinical, diagnostic, and therapeutic variables will be used to answer questions about survival and local recurrence, as well as questions about adverse events (AEs), morbidity data, and health-related quality of life (HRQOL) outcomes.
Spinal Column Tumor
This project aims to establish a network of spine oncology centers dedicated to prospective multicenter research of patients diagnosed with a primary tumor of the spine and will include a comprehensive prospective clinical database which will serve as a shared research platform. Demographic, clinical, diagnostic, and therapeutic variables will be used to answer questions about survival and local recurrence, as well as questions about adverse events (AEs), morbidity data, and health-related quality of life (HRQOL) outcomes.
Primary Tumor Research and Outcomes Network
-
University of California, Los Angeles, California, United States, 90095
UCSF Medical Center, San Francisco, California, United States, 94134
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States, 21205
Massachusetts General Hospital, Boston, Massachusetts, United States, 02114
Mayo Clinic, Rochester, Minnesota, United States, 55905
Memorial Sloan-Kettering Cancer Center, New York, New York, United States, 10065
Memorial Sloan Kettering Cancer Center, New York, New York, United States, 1275
Rhode Island Hospital, Providence, Rhode Island, United States, 02903
The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States, 77030
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to
ALL
No
AO Innovation Translation Center,
Jeremy Reynolds, MD, PRINCIPAL_INVESTIGATOR, Clinical Lead for Spinal Surgery at Oxford University Hospitals
2026-12